Virios Therapeutics, Inc. - stock earnings
VIRI Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q4 | -1.1 million USD | ? USD |
2023Q3 | -1.2 million USD | ? USD |
2023Q2 | -1.4 million USD | ? USD |
2023Q1 | -1.5 million USD | ? USD |
2022Q4 | -2.0 million USD | ? USD |
2022Q3 | -2.5 million USD | ? USD |
2022Q2 | -3.7 million USD | ? USD |
2022Q1 | -4.0 million USD | ? USD |
2021Q4 | -4.5 million USD | ? USD |
2021Q3 | -4.1 million USD | ? USD |
2021Q2 | -4.3 million USD | ? USD |
2021Q1 | -3.1 million USD | ? USD |
2020Q4 | -6.5 million USD | ? USD |
2020Q3 | -2.7 million USD | ? USD |
2020Q2 | -654585 USD | ? USD |
2020Q1 | -466553 USD | ? USD |
2019Q4 | -638589 USD | ? USD |
2019Q3 | -811819 USD | ? USD |
2019Q2 | -567856 USD | ? USD |
VIRI Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | -5.3 million USD | ? USD |
2022 | -12.2 million USD | ? USD |
2021 | -16.0 million USD | ? USD |
2020 | -10.3 million USD | ? USD |
2019 | -2.8 million USD | ? USD |
2018 | -2.1 million USD | ? USD |
VIRI
Price: $0.47
52 week price:
Earnings Per Share: -0.28 USD
P/E Ratio: -2.54
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 306080
Market Capitalization: 9.2 million